FDA’s Drug Safety Oversight Board Adds Staff To Manage Operations
Executive Summary
FDA is adding three new staffers dedicated to working full time on the operations and communications of the Drug Safety Oversight Board
You may also be interested in...
DSOB adds staffer
Mary Mease joins FDA's Drug Safety Oversight Board as a science policy analyst, the agency announced Nov. 4. Mease previously worked in the Center for Drug Evaluation & Research's Division of Scientific Investigators; she has also worked as a safety evaluator in the Office of Drug Safety's Division of Drug Risk Evaluation. Mease's appointment is expected to complete the board's staff (1"The Pink Sheet" Oct. 24, 2005, p. 5)...
DSOB adds staffer
Mary Mease joins FDA's Drug Safety Oversight Board as a science policy analyst, the agency announced Nov. 4. Mease previously worked in the Center for Drug Evaluation & Research's Division of Scientific Investigators; she has also worked as a safety evaluator in the Office of Drug Safety's Division of Drug Risk Evaluation. Mease's appointment is expected to complete the board's staff (1"The Pink Sheet" Oct. 24, 2005, p. 5)...
FDA Public Meeting On Rx Risk, Benefit Communication Slated For December
FDA will hold a public hearing on ways to better communicate information about drug risks and benefits, FDA Drug Safety Oversight Board Executive Director Susan Cummins said at the PDA/FDA Joint Regulatory Conference in Washington, D.C. on Sept. 13